Status:
COMPLETED
Intraoperative Versus CT Guided Celiac Plexus Neurolysis in Unresectable Pancreatic Cancer
Lead Sponsor:
Mansoura University
Conditions:
Pain, Chronic
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Many studies had stated that the coeliac plexus neurolysis (CPN) is a safe and effective treatment method of pain associated with pancreatic cancer. The neurolytic injectate is usually alcohol 50-100%...
Detailed Description
This study aimed to compare the efficacy of the surgical technique versus the per cutaneous computed tomographic guided technique of celiac plexus neurolysis for pain management in unresectable pancre...
Eligibility Criteria
Inclusion
- Adult patients suffering of pain from pancreatic cancer with baseline VAS≥5, scheduled for surgical assessment
- patients proven histololgically to be unresectable
- patients undergoing either biopsy or bypass surgery
Exclusion
- patient with resectable tumour will be excluded.
- Patient with coagulopathy.
- patient with aortic aneurysm.
- patient with any disease contraindicating any sympathetic blockade as advanced cardiac disease .
Key Trial Info
Start Date :
September 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2019
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT03770247
Start Date
September 1 2018
End Date
October 1 2019
Last Update
December 24 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mansoura university , gastrointestinal surgery center
Al Mansurah, Dakahlia Governorate, Egypt